Work

Final Results of a Randomized Phase III Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With a Dose-Intensified Epirubicin and Cyclophosphamide + Filgrastim as Neoadjuvant Treatment in Locally Advanced Breast Cancer: An EORTC-NCIC-SAKK Multicenter Study

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2003.05.135

Authors: P. Therasse, L. Mauriac, M. Welnicka-Jaskiewicz, P. Bruning, T. Cufer, H. Bonnefoi, E. Tomiak, K. I. Pritchard, A. Hamilton, M.J. Piccart

Institutions: European Organisation for Research and Treatment of Cancer, Sunnybrook Health Science Centre, Institute of Oncology Ljubljana, University Hospital of Geneva, European Organisation for Research and Treatment of Cancer, Institut Bergonié

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Amgen, National Cancer Institute

OpenAlex ID: W2164409215

FWCI: 6.111

Cites: 33

Cited by: 225

Related to: 10